PUK15 a Managed Care Cost-Offset Model for Ferric Citrate, an Experimental Phosphate Binder That Can Reduce the Use of Erythropoiesis-Stimulating Agents and Intravenous Iron in Hemodialysis Patients with Hyperphosphatemia
Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.835
https://www.valueinhealthjournal.com/article/S1098-3015(12)00900-X/fulltext
Title :
PUK15 a Managed Care Cost-Offset Model for Ferric Citrate, an Experimental Phosphate Binder That Can Reduce the Use of Erythropoiesis-Stimulating Agents and Intravenous Iron in Hemodialysis Patients with Hyperphosphatemia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)00900-X&doi=10.1016/j.jval.2012.03.835
First page :
A155
Section Title :
Urinary/Kidney Disorders
Open access? :
No
Section Order :
323